Literature DB >> 16054040

Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.

Gerald M Reaven1.   

Abstract

Although the concept of Syndrome X was introduced in the Banting Medal address of 1988 (Reaven, 1988), the notion that led to its genesis had started approximately 50 years earlier. In this short history, an attempt will be made to trace the two paths of scientific discovery that were formally merged in New Orleans in 1988 to form the scientific foundation of Syndrome X. In addition, the developments in the last 16 years that have led from the notion of Syndrome X to the broader concept of an Insulin Resistance Syndrome (IRS) will be briefly summarized.

Entities:  

Mesh:

Year:  2005        PMID: 16054040     DOI: 10.1016/j.cmet.2004.12.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  43 in total

Review 1.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 2.  The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

Authors:  Michaela Diamant; Maarten E Tushuizen
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

3.  Rimonabant--a new weapon in the war on obesity.

Authors:  Heinrich Taegtmeyer; Thomas R Lux
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

Review 4.  Homeostastic and non-homeostatic functions of melanocortin-3 receptors in the control of energy balance and metabolism.

Authors:  Karima Begriche; Gregory M Sutton; Andrew A Butler
Journal:  Physiol Behav       Date:  2011-04-13

5.  Race affects the association of obesity measures with insulin sensitivity.

Authors:  Jeannie Tay; Amy M Goss; W Timothy Garvey; Mark E Lockhart; Nikki C Bush; Michael J Quon; Gordon Fisher; Barbara A Gower
Journal:  Am J Clin Nutr       Date:  2020-03-01       Impact factor: 7.045

6.  Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes.

Authors:  Andrew A Bremer; Kimber L Stanhope; James L Graham; Bethany P Cummings; Wenli Wang; Benjamin R Saville; Peter J Havel
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

7.  Insulin resistance: from bit player to centre stage.

Authors:  Gerald M Reaven
Journal:  CMAJ       Date:  2011-01-10       Impact factor: 8.262

Review 8.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

9.  27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.

Authors:  Qian Wu; Tomonori Ishikawa; Rosa Sirianni; Hao Tang; Jeffrey G McDonald; Ivan S Yuhanna; Bonne Thompson; Luc Girard; Chieko Mineo; Rolf A Brekken; Michihisa Umetani; David M Euhus; Yang Xie; Philip W Shaul
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

10.  Adipose tissue plasticity in catch-up-growth trajectories to metabolic syndrome: hyperplastic versus hypertrophic catch-up fat.

Authors:  Abdul G Dulloo
Journal:  Diabetes       Date:  2009-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.